首页> 外文期刊>Pharmacopsychiatry >Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study
【24h】

Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study

机译:加入普瑞巴林在综合焦虑症和单极性抑郁症患者治疗患者中的疗效,并对EscitalOpram进行了早期的非响应:双盲安慰剂对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction This study tests the efficacy of pregabalin versus placebo as adjunctive treatment in patients with generalized anxiety disorder (GAD) comorbid with unipolar major depression (UMD) and with an early nonresponse to escitalopram.
机译:简介本研究测试了Prababalin与安慰剂的疗效,作为具有单极焦虑症(GAD)合并的患者的辅助治疗,与单极的主要抑郁症(UMD)和EscitalOpram的早期非响应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号